246 related articles for article (PubMed ID: 12489850)
1. Systemic tumor-targeted gene delivery by anti-transferrin receptor scFv-immunoliposomes.
Xu L; Huang CC; Huang W; Tang WH; Rait A; Yin YZ; Cruz I; Xiang LM; Pirollo KF; Chang EH
Mol Cancer Ther; 2002 Mar; 1(5):337-46. PubMed ID: 12489850
[TBL] [Abstract][Full Text] [Related]
2. Systemic p53 gene therapy of cancer with immunolipoplexes targeted by anti-transferrin receptor scFv.
Xu L; Tang WH; Huang CC; Alexander W; Xiang LM; Pirollo KF; Rait A; Chang EH
Mol Med; 2001 Oct; 7(10):723-34. PubMed ID: 11713371
[TBL] [Abstract][Full Text] [Related]
3. Tumor targeting using anti-her2 immunoliposomes.
Park JW; Kirpotin DB; Hong K; Shalaby R; Shao Y; Nielsen UB; Marks JD; Papahadjopoulos D; Benz CC
J Control Release; 2001 Jul; 74(1-3):95-113. PubMed ID: 11489487
[TBL] [Abstract][Full Text] [Related]
4. p53 gene therapy of human osteosarcoma using a transferrin-modified cationic liposome.
Nakase M; Inui M; Okumura K; Kamei T; Nakamura S; Tagawa T
Mol Cancer Ther; 2005 Apr; 4(4):625-31. PubMed ID: 15827336
[TBL] [Abstract][Full Text] [Related]
5. Generation and functional characterization of the anti-transferrin receptor single-chain antibody-GAL4 (TfRscFv-GAL4) fusion protein.
Ye Q; Hu H; Wang Z; Lu T; Hu Z; Zeng X; Zhang S; Liu J; Lei P; Wang CY; Ye Z; Shen G
BMC Biotechnol; 2012 Nov; 12():91. PubMed ID: 23192001
[TBL] [Abstract][Full Text] [Related]
6. Tumor-targeted p53-gene therapy enhances the efficacy of conventional chemo/radiotherapy.
Xu L; Pirollo KF; Chang EH
J Control Release; 2001 Jul; 74(1-3):115-28. PubMed ID: 11489488
[TBL] [Abstract][Full Text] [Related]
7. Single-chain antibody-mediated gene delivery into ErbB2-positive human breast cancer cells.
Li X; Stuckert P; Bosch I; Marks JD; Marasco WA
Cancer Gene Ther; 2001 Aug; 8(8):555-65. PubMed ID: 11571533
[TBL] [Abstract][Full Text] [Related]
8. A sterically stabilized immunolipoplex for systemic administration of a therapeutic gene.
Yu W; Pirollo KF; Rait A; Yu B; Xiang LM; Huang WQ; Zhou Q; Ertem G; Chang EH
Gene Ther; 2004 Oct; 11(19):1434-40. PubMed ID: 15229629
[TBL] [Abstract][Full Text] [Related]
9. Future directions of liposome- and immunoliposome-based cancer therapeutics.
Park JW; Benz CC; Martin FJ
Semin Oncol; 2004 Dec; 31(6 Suppl 13):196-205. PubMed ID: 15717745
[TBL] [Abstract][Full Text] [Related]
10. Anti-HER2 immunoliposomes: enhanced efficacy attributable to targeted delivery.
Park JW; Hong K; Kirpotin DB; Colbern G; Shalaby R; Baselga J; Shao Y; Nielsen UB; Marks JD; Moore D; Papahadjopoulos D; Benz CC
Clin Cancer Res; 2002 Apr; 8(4):1172-81. PubMed ID: 11948130
[TBL] [Abstract][Full Text] [Related]
11. Antibody targeted gene transfer to endothelium.
Tan PH; Manunta M; Ardjomand N; Xue SA; Larkin DF; Haskard DO; Taylor KM; George AJ
J Gene Med; 2003 Apr; 5(4):311-23. PubMed ID: 12692865
[TBL] [Abstract][Full Text] [Related]
12. [Expression, purification and activity analysis of anti-human transferrin receptor scFv].
Zhao LX; Yan B; Xu L; Jiang SW; Zhang YY; Yang ZX; Zhou XW; Huang PT
Sheng Wu Gong Cheng Xue Bao; 2006 May; 22(3):488-91. PubMed ID: 16755932
[TBL] [Abstract][Full Text] [Related]
13. Generation of immunoliposomes using recombinant single-chain Fv fragments bound to Ni-NTA-liposomes.
Rüger R; Müller D; Fahr A; Kontermann RE
J Drug Target; 2005 Aug; 13(7):399-406. PubMed ID: 16308208
[TBL] [Abstract][Full Text] [Related]
14. Pharmacokinetics and brain uptake of a genetically engineered bifunctional fusion antibody targeting the mouse transferrin receptor.
Boado RJ; Zhou QH; Lu JZ; Hui EK; Pardridge WM
Mol Pharm; 2010 Feb; 7(1):237-44. PubMed ID: 19921848
[TBL] [Abstract][Full Text] [Related]
15. Enhancement of p53 gene transfer efficiency in hepatic tumor mediated by transferrin receptor through trans-arterial delivery.
Lu Q; Teng GJ; Zhang Y; Niu HZ; Zhu GY; An YL; Yu H; Li GZ; Qiu DH; Wu CG
Cancer Biol Ther; 2008 Feb; 7(2):218-24. PubMed ID: 18347429
[TBL] [Abstract][Full Text] [Related]
16. Construction of single chain Fv antibody against transferrin receptor and its protein fusion with alkaline phosphatase.
Yang DF; Zhu HF; Wang ZH; Shen GX; Tian DY
World J Gastroenterol; 2005 Jun; 11(21):3300-3. PubMed ID: 15929188
[TBL] [Abstract][Full Text] [Related]
17. Site-specific expression of transferrin receptor by human colon cancer cells directly correlates with eradication by antitransferrin recombinant immunotoxin.
Shinohara H; Fan D; Ozawa S; Yano S; Van Arsdell M; Viner JL; Beers R; Pastan I; Fidler IJ
Int J Oncol; 2000 Oct; 17(4):643-51. PubMed ID: 10995873
[TBL] [Abstract][Full Text] [Related]
18. Inclusion of a furin-sensitive spacer enhances the cytotoxicity of ribotoxin restrictocin containing recombinant single-chain immunotoxins.
Goyal A; Batra JK
Biochem J; 2000 Jan; 345 Pt 2(Pt 2):247-54. PubMed ID: 10620501
[TBL] [Abstract][Full Text] [Related]
19. siRNA delivery by a transferrin-associated lipid-based vector: a non-viral strategy to mediate gene silencing.
Cardoso AL; Simões S; de Almeida LP; Pelisek J; Culmsee C; Wagner E; Pedroso de Lima MC
J Gene Med; 2007 Mar; 9(3):170-83. PubMed ID: 17351968
[TBL] [Abstract][Full Text] [Related]
20. PEGylated immunoliposome-loaded endoglin single-chain antibody enhances anti-tumor capacity of porcine α1,3GT gene.
Huang Y; Huang Y; He J; Wang H; Luo Y; Li Y; Liu J; Zhong L; Zhao Y
Biomaterials; 2019 Oct; 217():119231. PubMed ID: 31254933
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
